Justice Targets ‘Serious’ GMP Issues, Hears More from Whistleblowers
This article was originally published in The Gold Sheet
Executive Summary
The Justice Department is imposing harsh penalties on manufacturers that commit serious GMP violations and this trend will continue in the foreseeable future. DOJ is also getting more calls from FDA and whistleblowers alleging GMP violations under the False Claims Act.